Skip NavigationDepartment of Transportation Logo  U.S. Department of Transportation Keyword Links | Contact Us | Español

Federal Motor Carrier Safety Administration

Home Rules & Regulations Registration & Licensing Forms Safety & Security Facts & Research Cross Border About FMCSA
  Home > Rules & Regulations > Regulations
 
Overview
Federal Regulations
All
Driver
Vehicle
Company
FMCSA Hazmat
Regulatory Guidance
Rulemakings and Notices
Final Rules
Interim Final Rules
Proposed Rules
Notices
Topics of Interest
Hours of Service (HOS)
Hazardous Materials
Medical Program
NAFTA Rules
Drug & Alcohol Testing
 
    

Regulations

  Print this page Print    

40.177   What does the second laboratory do with the split specimen when it is tested to reconfirm the presence of a drug or drug metabolite?


(a) As the laboratory testing the split specimen, you must test the split specimen for the drug(s)/drug metabolite(s) detected in the primary specimen.

(b) You must conduct this test without regard to the cutoff concentrations of 40.87 .

(c) If the test fails to reconfirm the presence of the drug(s)/drug metabolite(s) that were reported positive in the primary specimen, you must conduct validity tests in an attempt to determine the reason for being unable to reconfirm the presence of the drug(s)/metabolite(s). You should conduct the same validity tests as you would conduct on a primary specimen set forth in 40.91 .

(d) In addition, if the test fails to reconfirm the presence of the drugs/drugs metabolites or validity criteria that were reported in the primary specimen, you may transmit the specimen or an aliquot of it to another HHS-certified laboratory that will conduct another reconfirmation test.


Go To Top of Page